| Ytd | 57.58% | |
| 1y | 248.44% |
| Open | 60.75 | Prev Close | 60.89 | Low | 60.20 | High | 61.97 | Mkt Cap | 5.60B |
| Vol | 0.00 | Avg Vol | 1.94M | EPS | -0.45 | P/E | -133.80 | Forward P/E | 11.17 |
| Beta | 1.04 | Short Ratio | 5.91 | Inst. Own | 110.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 54.80 | 200-d Avg | 39.34 | 1yr Est | 71.71 |
TVTX News
Travere Therapeutics is downgraded from Buy to Hold after a >130% rally, reflecting competitive risk
Empowered Funds LLC boosted its holdings in Travere Therapeutics, Inc. (NASDAQ: TVTX) by 2,719.8% in
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company m
US stocks rise, Wynn Resorts beat earnings expectations, share price jumps 10.9%. Other companies re
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday&#
Travere Therapeutics NASDAQ: TVTX reported second-quarter results marked by record FILSPARI demand a
Travere Therapeutics, Inc. (TVTX) Q2 2026 Earnings Call Transcript
While the top- and bottom-line numbers for Travere (TVTX) give a sense of how the business performed
Travere Therapeutics (TVTX) came out with a quarterly loss of $0.37 per share versus the Zacks Conse
Gainers Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 42.0% to $1.42 during Tuesday'
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today reported its second quar
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report
NEW YORK, July 27, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inves
NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on July 1
HONG KONG, July 8, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) announced the closing of
Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI's
SAN DIEGO--(BUSINESS WIRE)---- $TVTX--Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced tha
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on June 1
Travere Therapeutics, Inc. (TVTX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)---- $TVTX--Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced lon
HONG KONG, June 4, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) announced that it has en
Dow Jones up 200 points, Avanos Medical Inc rose on going-private deal. Big gainers include AVNS, TV
Travere Therapeutics' stock declines as FDA extends review of key kidney drug. Q4 sales forecast
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earning
Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarte
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
During the session on Thursday, 461 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnin